Intuitive Surgical Updates Bylaws to Implement Universal Proxy Rules and Strengthen Shareholder Meeting Procedures

Universal Proxy Rule Compliance Framework

Intuitive Surgical's Board of Directors amended the company's bylaws to implement provisions aligned with the SEC's universal proxy rules, which were adopted to standardize shareholder communication practices in director elections. The disclosure states that the company will now disregard votes for nominees made by shareholders that do not comply with universal proxy requirements. A central component of this compliance framework is the requirement that shareholder proponents must solicit the holders of at least 67% of outstanding shares before they can present their own director nominees at shareholder meetings. This threshold represents a significant barrier to activist campaigns and ensures that shareholder nominations reflect broader support among the investor base.

The implementation of these provisions reflects ongoing regulatory evolution in corporate governance. The amendments give Intuitive Surgical a formal mechanism to enforce compliance with universal proxy standards without requiring case-by-case legal determinations at shareholder meetings. By embedding these requirements directly into the bylaws, the company creates clarity around which nominations will be counted and provides shareholders and the company's governance team with transparent criteria ahead of proxy contests.

Enhanced Disclosure Requirements for Shareholder Proposals and Director Nominations

The amended bylaws introduce refined disclosure obligations for shareholders seeking to nominate directors or submit proposals for shareholder consideration. The company has clarified disclosures of synthetic equity holdings by utilizing SEC-defined terminology, making it clearer how investors structure derivative positions and what economic interests they may hold in company performance. Additionally, shareholders must now disclose the dates and intent of their investment, allowing other shareholders and the board to assess the timing and motivations behind proposals. The disclosure requirements also mandate that the full language of any proposed bylaw amendments and related information be included in the proxy statement, eliminating ambiguity about what shareholders are voting on.

These enhanced disclosure measures are designed to provide transparency to the broader shareholder base about who is driving governance proposals and what financial interests may underlie those efforts. By requiring disclosure of investment intent and timing, the company enables other shareholders to evaluate whether a proposal reflects long-term strategic input or shorter-term tactical positioning. The requirement to include full bylaw language in the proxy statement removes opportunities for ambiguous or incomplete descriptions of proposed changes, ensuring that all shareholders voting on such matters have access to the complete text.

Procedural Restrictions on Director Nominations

The amended bylaws establish clearer procedural mechanics governing the nomination of director candidates. A key change prohibits shareholders from nominating more director candidates than the number of positions actually up for election at the applicable shareholder meeting. This provision prevents the practice of slate-packing, in which activist investors present a larger slate of nominees than necessary, potentially creating confusion or strategic voting difficulties. By capping nominations to the number of available seats, the company ensures that shareholders receive a focused ballot reflecting genuine governance choices.

The amendments also require that a shareholder be a record holder—not merely a beneficial owner—to request the required questionnaires for a nominee to complete. This requirement ensures that those initiating director nominations have a formal ownership stake and not merely derivative exposure to the company. Furthermore, the bylaws now mandate that the shareholder be present in person at the shareholder meeting to proceed with their nominated candidates. These procedural safeguards create practical and documentation-based requirements that ensure the integrity of the nomination process and prevent remote or indirect manipulation of the director selection process.

Proxy Card Color and Solicitation Standards

The amended bylaws introduce a requirement that any shareholder directly or indirectly soliciting proxies from other shareholders must use a proxy card color other than white. This seemingly technical provision has practical significance in preventing confusion between official company proxy materials, which traditionally use white proxy cards, and materials distributed by activist or dissident shareholders. By mandating a different color for shareholder-initiated solicitations, the company creates visual differentiation that allows shareholders to quickly identify the source and nature of proxy materials they receive.

This amendment addresses a longstanding governance concern about shareholder confusion in proxy contests. When multiple proxy cards circulate during a contested election, the visual distinction provided by color coding can materially reduce voting errors and ensure that shareholders are voting on the materials they intend to vote on. The provision reflects best practices in corporate governance by reducing the potential for unintentional voting mistakes that could affect meeting outcomes.

Special Meeting Request Procedures and Record Date Logistics

The amended bylaws establish new logistics for shareholders seeking to request a record date for determining eligibility to call a special meeting. The disclosure indicates that the company has formalized procedures allowing shareholders to make such requests and that the process now includes specific disclosure requirements. Shareholders requesting special meeting rights must now provide disclosures similar to those required when submitting director nominations or proposals at annual meetings, including information about their holdings, investment intent, and beneficial ownership structures.

These procedural changes standardize the information provided by shareholders across different governance contexts. By requiring consistent disclosure whether shareholders are seeking to nominate directors, submit proposals, or call special meetings, the company reduces opportunities for selective disclosure and ensures that decision-making bodies and the broader shareholder base have complete information about who is driving governance initiatives.

Voting Standards for Non-Election Corporate Actions

The amended bylaws change the voting standard for corporate actions other than director elections to require a majority of votes cast, excluding abstentions and broker non-votes. Under this standard, only votes actually cast in favor of or against a measure are counted, rather than counting the total shares outstanding or shares present at the meeting. This change simplifies the voting calculation and means that abstentions and shares held by brokers without voting instructions do not dilute the voting power of shareholders who actively participate in the voting process.

The shift to a votes-cast majority standard reflects a governance philosophy that prioritizes the clear intent of engaged shareholders over procedural calculations that include non-participants. This change could materially affect the approval thresholds for certain corporate actions, potentially making it easier for management-backed proposals to achieve approval if a significant portion of shares are held by passive investors or result in abstentions. The disclosure does not indicate that this change applies to director elections, which typically remain subject to plurality or majority voting standards established under Delaware law or specific company bylaws.

Technical and Conforming Amendments

In addition to the substantive governance changes described above, the amended bylaws include various technical amendments designed to conform the company's governance documents to applicable law. The filing indicates that these amendments address procedural provisions, formatting, and other matters necessary to ensure that the bylaws remain consistent with current Delaware corporation law and SEC regulations. The company has incorporated the full text of the Amended and Restated Bylaws as Exhibit 3.1 to its filing, making the complete document available to investors and other stakeholders.

These technical conforming amendments represent standard corporate governance maintenance. They ensure that provisions addressing procedural matters, meeting logistics, and administrative requirements remain aligned with evolving legal standards without changing the substantive governance framework. The company's detailed inclusion of the full bylaw text reflects transparency and allows institutional shareholders, governance professionals, and other stakeholders to review the precise language and identify any impacts on their shareholder rights or voting procedures.

Investor Implications and Governance Evolution

The comprehensive nature of the bylaw amendments reflects broader governance trends in large-cap public companies, particularly in capital-intensive industries such as surgical robotics and medical devices. By implementing universal proxy rules, enhancing disclosure requirements, and clarifying procedural mechanics, Intuitive Surgical is adapting its governance structure to standards that major asset managers and institutional investors increasingly expect. The amendments may affect the practical ability of activist shareholders to mount director contests or present alternative governance proposals, given the new disclosure thresholds, nominating caps, and procedural requirements.

For investors monitoring the company's governance practices, the amendments represent a shift toward greater procedural formality and disclosure in shareholder engagement. These changes could reduce the likelihood of surprise governance contests or activist campaigns, as the heightened disclosure requirements and procedural barriers require substantially more preparation and shareholder support before such efforts can advance. Investors should review the full amended bylaws to assess how these provisions may affect their ability to nominate directors or submit proposals at future shareholder meetings.

Board Authority and Governance Framework Update

The Board of Directors' decision to amend and restate the bylaws on July 23, 2026, reflects the board's assessment that these governance updates are necessary to ensure compliance with SEC regulations and to strengthen the company's governance framework. The filing does not indicate that shareholders voted on these amendments prior to their adoption, which is consistent with Delaware law and most state corporation statutes allowing boards to amend bylaws without shareholder approval, subject to any conflicting shareholder-approved bylaw provisions.

The comprehensive scope of the amendments—addressing proxy rules, disclosure requirements, nomination procedures, voting standards, and special meeting logistics—suggests that the board conducted a thorough governance review rather than making isolated, incremental changes. This comprehensive approach may reflect input from the company's corporate governance team, legal advisors, and potentially feedback from institutional shareholders regarding governance best practices and regulatory expectations in the medical device and surgical robotics sectors.